Satvat Ali J.
CIK: 0001621788
Director
Primary company: BridgeBio Pharma, Inc. (BBIO)
Satvat Ali J. is a corporate insider at BridgeBio Pharma, Inc. (BBIO) filing SEC Form 4 transactions. 42 transactions across 3 companies, totaling $72,005,575 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 5,277 | $68.92 | $364K | 5,277 | 6/22/2026 Filed: 6/22/2026 | Filing → | |
| Award | 3,990 | - | - | 169,983 | 6/22/2026 Filed: 6/22/2026 | Filing → | |
| Award | 60,000 | $1.45 | $87K | 60,000 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
| Award | 30,000 | - | - | 30,000 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
| Award | 8,425 | - | - | 8,425 | 6/20/2025 Filed: 6/24/2025 | Filing → | |
| Award | 6,589 | - | - | 165,993 | 6/20/2025 Filed: 6/24/2025 | Filing → | |
| Award | 112,000 | - | - | 112,000 | 6/12/2025 Filed: 6/13/2025 | Filing → | |
| Exercise | 39,851 | - | - | 0 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Exercise | 39,851 | - | - | 0 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Exercise | 79,702 | - | - | 0 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Exercise | 39,851 | $26.21 | $1.04M | 159,404 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Exercise | 39,851 | $16.68 | $665K | 119,553 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Exercise | 79,702 | $10.99 | $876K | 79,702 | 12/30/2024 Filed: 12/31/2024 | Filing → | |
| Award | 26,014 | - | - | 26,014 | 6/21/2024 Filed: 6/25/2024 | Filing → | |
| Award | 51,501 | $0.00 | $0 | 51,501 | 6/21/2023 Filed: 6/23/2023 | Filing → | |
| Award | 104,921 | $0.00 | $0 | 104,921 | 6/22/2022 Filed: 6/24/2022 | Filing → | |
| Award | 38,895 | $0.00 | $0 | 38,895 | 6/17/2021 Filed: 6/22/2021 | Filing → | |
Eidos Therapeutics, Inc. EIDX | Disposition | 43,056 | - | - | 0 | 1/26/2021 Filed: 1/28/2021 | Filing → |
Eidos Therapeutics, Inc. EIDX | Disposition | 21,528 | - | - | 0 | 1/26/2021 Filed: 1/28/2021 | Filing → |
Eidos Therapeutics, Inc. EIDX | Disposition | 21,528 | - | - | 0 | 1/26/2021 Filed: 1/28/2021 | Filing → |
Type
Award
Shares
5,277
Price
$68.92
Value
$364K
Type
Award
Shares
3,990
Price
-
Value
-
Type
Award
Shares
60,000
Price
$1.45
Value
$87K
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
8,425
Price
-
Value
-
Type
Award
Shares
6,589
Price
-
Value
-
Type
Award
Shares
112,000
Price
-
Value
-
Type
Exercise
Shares
39,851
Price
-
Value
-
Type
Exercise
Shares
39,851
Price
-
Value
-
Type
Exercise
Shares
79,702
Price
-
Value
-
Type
Exercise
Shares
39,851
Price
$26.21
Value
$1.04M
Type
Exercise
Shares
39,851
Price
$16.68
Value
$665K
Type
Exercise
Shares
79,702
Price
$10.99
Value
$876K
Type
Award
Shares
26,014
Price
-
Value
-
Type
Award
Shares
51,501
Price
$0.00
Value
$0
Type
Award
Shares
104,921
Price
$0.00
Value
$0
Type
Award
Shares
38,895
Price
$0.00
Value
$0
Eidos Therapeutics, Inc.
EIDX
Type
Disposition
Shares
43,056
Price
-
Value
-
Eidos Therapeutics, Inc.
EIDX
Type
Disposition
Shares
21,528
Price
-
Value
-
Eidos Therapeutics, Inc.
EIDX
Type
Disposition
Shares
21,528
Price
-
Value
-
AI Agent
Try asking...